Evidence map›Paper›PMID 34448054›Full record

ArticleAnnals of surgical oncology2022

Percutaneous Cementoplasty for the Pelvis in Bone Metastasis: 12-Year Experience.

Jong Woong Park, Hyun-Ju Lim, Hyun Guy Kang, June Hyuk Kim, Han-Soo Kim

Open access · bronzeAbstract read
In one paragraph

Article in Annals of surgical oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 34 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Management of metastatic bone disease of the pelvis: current concepts.European journal of trauma and emergency surgery : official publication of the European Trauma Society · 2024
    Review
  12. Review
  13. Review
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Jong Woong ParkOrthopaedic Oncology Clinic, National Cancer Center, Goyang, Gyeonggi-do, Republic of Korea.
Hyun-Ju LimDepartment of Radiology, National Cancer Center, Goyang, Gyeonggi-do, Republic of Korea.
Hyun Guy KangOrthopaedic Oncology Clinic, National Cancer Center, Goyang, Gyeonggi-do, Republic of Korea. ostumor@ncc.re.kr.
June Hyuk KimOrthopaedic Oncology Clinic, National Cancer Center, Goyang, Gyeonggi-do, Republic of Korea.
Han-Soo KimDepartment of Orthopaedic Surgery, Seoul National University Hospital, Seoul, Republic of Korea.
National Cancer Center · KRSeoul National University Hospital · KR

Funding

National Research Foundation of Korea 2020R1C1C1010776
6 · The paper itself

Abstract

backgroundIn advanced cancer patients, pelvic bone metastasis often causes pain and gait disturbance. The use of percutaneous bone cement [polymethylmethacrylate (PMMA)] injection for pain management and strengthening in pelvic bone metastasis has rarely been reported. To evaluate this method, we aimed to determine surgical outcomes and complications over a long-term follow-up period using a large patient group. PATIENTS AND

methodsWe retrospectively collected data from 178 patients who underwent percutaneous cementoplasty for pelvic metastatic lesions, 201 in total. Surgical outcomes evaluated included pain reduction and improvement of ambulation. Mortality within 1 month after procedure and pulmonary embolism caused by thrombus, fat, tumor emboli, or bone cement were investigated as surgical complications. For long-term survivors, pain relapse and mechanical failure were analyzed. The mean follow-up period was 12.6 months, and there were 159 fatalities at last follow-up.

resultsThe mean regional pain numerical rating scale scores decreased from 6.1 preoperatively to 2.4 1 month after procedure (p < 0.01). Gait function was maintained, worsened, and uncheckable in 68%, 24%, and 8% of patients, respectively, 1 month after procedure. Of long-term survivors followed up for > 12 months (n = 53), there were no significant changes in serial plain radiographs, and regional pain aggravation was observed in 9%. Pulmonary cement embolism and bone cement implantation syndrome was observed in 11% and 10%, respectively. However, all patients with these complications were asymptomatic.

conclusionsPercutaneous cement injection into the pelvis is a feasible and safe palliative surgical option for patients with advanced malignancy in terms of pain reduction and maintenance of ambulatory function under regional anesthesia.

Indexed as

Bone NeoplasmsCementoplastyPelvic BonesBone CementsHumansPelvisRetrospective StudiesTreatment OutcomeBone Cements

Identifiers

PMID34448054
PMCPMC8390074
OpenAlexW3194538345

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.